GENPACT LIMITED

GNYSECIK 1398659Industrials / Business Servicesfiscal year ends December70 quarters since 2009

Revenue, Q3 FY2026
$1.4B
+7.3% on Q3 FY2025
Net income
$152M
+4.0% on Q3 FY2025
Free cash flow
$76M
−73.8% on Q3 FY2025
Diluted EPS
$0.89
+7.2% on Q3 FY2025
Revenue, TTM
$5.3B
trailing four quarters
Net margin, TTM
11.0%
net income $588M
Free cash flow, TTM
$357M
$429M less $72M capex
Cash and equivalents
$499M
long-term debt $1.1B, Sep 30, 2026
Shares, 12-month change
−3.0%
167M shares, Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$124M
1.7% of market value
Market value
$7.3B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, GENPACT LIMITED reported revenue of $1.4B, +7.3% on Q3 FY2025, and net income of $152M (+4.0%). Operating margin was 15.2%. Free cash flow, operating cash flow less capital expenditures, was $76M ($93M less $17M). Diluted earnings per share were $0.89.

Share price

Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

G daily priceSplit-adjusted, US dollars; an earnings release
Nov 13, 2026O $43.01 · H $43.88 · L $42.83 · C $43.61 · +1.11% on the dayOver the range: −3.20%, Nov 14, 2025 to Nov 13, 2026
$26$32$38$44$50Nov 25Jan 26Apr 26Jun 26Sep 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 6, 2026.

Revenue and net incomeRevenueNet income
$0$500M$1.0B$1.5BQ4'22, Revenue: $1.1BQ4'22, Net income: $90MQ4'22Q1'23, Revenue: $1.1BQ1'23, Net income: $106MQ1'23Q2'23, Revenue: $1.1BQ2'23, Net income: $116MQ2'23Q3'23, Revenue: $1.1BQ3'23, Net income: $118MQ3'23Q4'23, Revenue: $1.1BQ4'23, Net income: $291MQ4'23Q1'24, Revenue: $1.1BQ1'24, Net income: $117MQ1'24Q2'24, Revenue: $1.2BQ2'24, Net income: $122MQ2'24Q3'24, Revenue: $1.2BQ3'24, Net income: $133MQ3'24Q4'24, Revenue: $1.2BQ4'24, Net income: $142MQ4'24Q1'25, Revenue: $1.2BQ1'25, Net income: $131MQ1'25Q2'25, Revenue: $1.3BQ2'25, Net income: $133MQ2'25Q3'25, Revenue: $1.3BQ3'25, Net income: $146MQ3'25Q4'25, Revenue: $1.3BQ4'25, Net income: $143MQ4'25Q1'26, Revenue: $1.3BQ1'26, Net income: $148MQ1'26Q2'26, Revenue: $1.3BQ2'26, Net income: $146MQ2'26Q3'26, Revenue: $1.4BQ3'26, Net income: $152MQ3'26$0$500M$1.0B$1.5BQ4'22, Revenue: $1.1BQ4'22, Net income: $90MQ4'22Q1'23, Revenue: $1.1BQ1'23, Net income: $106MQ1'23Q2'23, Revenue: $1.1BQ2'23, Net income: $116MQ2'23Q3'23, Revenue: $1.1BQ3'23, Net income: $118MQ3'23Q4'23, Revenue: $1.1BQ4'23, Net income: $291MQ4'23Q1'24, Revenue: $1.1BQ1'24, Net income: $117MQ1'24Q2'24, Revenue: $1.2BQ2'24, Net income: $122MQ2'24Q3'24, Revenue: $1.2BQ3'24, Net income: $133MQ3'24Q4'24, Revenue: $1.2BQ4'24, Net income: $142MQ4'24Q1'25, Revenue: $1.2BQ1'25, Net income: $131MQ1'25Q2'25, Revenue: $1.3BQ2'25, Net income: $133MQ2'25Q3'25, Revenue: $1.3BQ3'25, Net income: $146MQ3'25Q4'25, Revenue: $1.3BQ4'25, Net income: $143MQ4'25Q1'26, Revenue: $1.3BQ1'26, Net income: $148MQ1'26Q2'26, Revenue: $1.3BQ2'26, Net income: $146MQ2'26Q3'26, Revenue: $1.4BQ3'26, Net income: $152MQ3'26$0$500M$1.0B$1.5BQ4'22, Revenue: $1.1BQ4'22, Net income: $90MQ1'23, Revenue: $1.1BQ1'23, Net income: $106MQ1'23Q2'23, Revenue: $1.1BQ2'23, Net income: $116MQ3'23, Revenue: $1.1BQ3'23, Net income: $118MQ3'23Q4'23, Revenue: $1.1BQ4'23, Net income: $291MQ1'24, Revenue: $1.1BQ1'24, Net income: $117MQ1'24Q2'24, Revenue: $1.2BQ2'24, Net income: $122MQ3'24, Revenue: $1.2BQ3'24, Net income: $133MQ3'24Q4'24, Revenue: $1.2BQ4'24, Net income: $142MQ1'25, Revenue: $1.2BQ1'25, Net income: $131MQ1'25Q2'25, Revenue: $1.3BQ2'25, Net income: $133MQ3'25, Revenue: $1.3BQ3'25, Net income: $146MQ3'25Q4'25, Revenue: $1.3BQ4'25, Net income: $143MQ1'26, Revenue: $1.3BQ1'26, Net income: $148MQ1'26Q2'26, Revenue: $1.3BQ2'26, Net income: $146MQ3'26, Revenue: $1.4BQ3'26, Net income: $152MQ3'26

Net income losses drawn in red.

Free cash flow
−$100M$0$100M$200M$300MQ4'22, Free cash flow: $214MQ4'22Q1'23, Free cash flow: −$47MQ1'23Q2'23, Free cash flow: $160MQ2'23Q3'23, Free cash flow: $148MQ3'23Q4'23, Free cash flow: $174MQ4'23Q1'24, Free cash flow: −$50MQ1'24Q2'24, Free cash flow: $190MQ2'24Q3'24, Free cash flow: $209MQ3'24Q4'24, Free cash flow: $184MQ4'24Q1'25, Free cash flow: $18MQ1'25Q2'25, Free cash flow: $155MQ2'25Q3'25, Free cash flow: $292MQ3'25Q4'25, Free cash flow: $269MQ4'25Q1'26, Free cash flow: −$47MQ1'26Q2'26, Free cash flow: $59MQ2'26Q3'26, Free cash flow: $76MQ3'26−$100M$0$100M$200M$300MQ4'22, Free cash flow: $214MQ4'22Q1'23, Free cash flow: −$47MQ1'23Q2'23, Free cash flow: $160MQ2'23Q3'23, Free cash flow: $148MQ3'23Q4'23, Free cash flow: $174MQ4'23Q1'24, Free cash flow: −$50MQ1'24Q2'24, Free cash flow: $190MQ2'24Q3'24, Free cash flow: $209MQ3'24Q4'24, Free cash flow: $184MQ4'24Q1'25, Free cash flow: $18MQ1'25Q2'25, Free cash flow: $155MQ2'25Q3'25, Free cash flow: $292MQ3'25Q4'25, Free cash flow: $269MQ4'25Q1'26, Free cash flow: −$47MQ1'26Q2'26, Free cash flow: $59MQ2'26Q3'26, Free cash flow: $76MQ3'26−$100M$0$100M$200M$300MQ4'22, Free cash flow: $214MQ1'23, Free cash flow: −$47MQ1'23Q2'23, Free cash flow: $160MQ3'23, Free cash flow: $148MQ3'23Q4'23, Free cash flow: $174MQ1'24, Free cash flow: −$50MQ1'24Q2'24, Free cash flow: $190MQ3'24, Free cash flow: $209MQ3'24Q4'24, Free cash flow: $184MQ1'25, Free cash flow: $18MQ1'25Q2'25, Free cash flow: $155MQ3'25, Free cash flow: $292MQ3'25Q4'25, Free cash flow: $269MQ1'26, Free cash flow: −$47MQ1'26Q2'26, Free cash flow: $59MQ3'26, Free cash flow: $76MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$500M$1.0B$1.5BQ4'22, Cash and equivalents: $647MQ4'22, Long-term debt: $1.2BQ4'22Q1'23, Cash and equivalents: $552MQ1'23, Long-term debt: $1.2BQ1'23Q2'23, Cash and equivalents: $491MQ2'23, Long-term debt: $1.2BQ2'23Q3'23, Cash and equivalents: $541MQ3'23, Long-term debt: $1.2BQ3'23Q4'23, Cash and equivalents: $584MQ4'23, Long-term debt: $825MQ4'23Q1'24, Cash and equivalents: $478MQ1'24, Long-term debt: $818MQ1'24Q2'24, Cash and equivalents: $914MQ2'24, Long-term debt: $1.2BQ2'24Q3'24, Cash and equivalents: $1.0BQ3'24, Long-term debt: $1.2BQ3'24Q4'24, Cash and equivalents: $648MQ4'24, Long-term debt: $1.2BQ4'24Q1'25, Cash and equivalents: $562MQ1'25, Long-term debt: $1.2BQ1'25Q2'25, Cash and equivalents: $663MQ2'25, Long-term debt: $833MQ2'25Q3'25, Cash and equivalents: $741MQ3'25, Long-term debt: $827MQ3'25Q4'25, Cash and equivalents: $854MQ4'25, Long-term debt: $1.2BQ4'25Q1'26, Cash and equivalents: $578MQ1'26, Long-term debt: $1.2BQ1'26Q2'26, Cash and equivalents: $517MQ2'26, Long-term debt: $1.2BQ2'26Q3'26, Cash and equivalents: $499MQ3'26, Long-term debt: $1.1BQ3'26$0$500M$1.0B$1.5BQ4'22, Cash and equivalents: $647MQ4'22, Long-term debt: $1.2BQ4'22Q1'23, Cash and equivalents: $552MQ1'23, Long-term debt: $1.2BQ1'23Q2'23, Cash and equivalents: $491MQ2'23, Long-term debt: $1.2BQ2'23Q3'23, Cash and equivalents: $541MQ3'23, Long-term debt: $1.2BQ3'23Q4'23, Cash and equivalents: $584MQ4'23, Long-term debt: $825MQ4'23Q1'24, Cash and equivalents: $478MQ1'24, Long-term debt: $818MQ1'24Q2'24, Cash and equivalents: $914MQ2'24, Long-term debt: $1.2BQ2'24Q3'24, Cash and equivalents: $1.0BQ3'24, Long-term debt: $1.2BQ3'24Q4'24, Cash and equivalents: $648MQ4'24, Long-term debt: $1.2BQ4'24Q1'25, Cash and equivalents: $562MQ1'25, Long-term debt: $1.2BQ1'25Q2'25, Cash and equivalents: $663MQ2'25, Long-term debt: $833MQ2'25Q3'25, Cash and equivalents: $741MQ3'25, Long-term debt: $827MQ3'25Q4'25, Cash and equivalents: $854MQ4'25, Long-term debt: $1.2BQ4'25Q1'26, Cash and equivalents: $578MQ1'26, Long-term debt: $1.2BQ1'26Q2'26, Cash and equivalents: $517MQ2'26, Long-term debt: $1.2BQ2'26Q3'26, Cash and equivalents: $499MQ3'26, Long-term debt: $1.1BQ3'26$0$500M$1.0B$1.5BQ4'22, Cash and equivalents: $647MQ4'22, Long-term debt: $1.2BQ1'23, Cash and equivalents: $552MQ1'23, Long-term debt: $1.2BQ1'23Q2'23, Cash and equivalents: $491MQ2'23, Long-term debt: $1.2BQ3'23, Cash and equivalents: $541MQ3'23, Long-term debt: $1.2BQ3'23Q4'23, Cash and equivalents: $584MQ4'23, Long-term debt: $825MQ1'24, Cash and equivalents: $478MQ1'24, Long-term debt: $818MQ1'24Q2'24, Cash and equivalents: $914MQ2'24, Long-term debt: $1.2BQ3'24, Cash and equivalents: $1.0BQ3'24, Long-term debt: $1.2BQ3'24Q4'24, Cash and equivalents: $648MQ4'24, Long-term debt: $1.2BQ1'25, Cash and equivalents: $562MQ1'25, Long-term debt: $1.2BQ1'25Q2'25, Cash and equivalents: $663MQ2'25, Long-term debt: $833MQ3'25, Cash and equivalents: $741MQ3'25, Long-term debt: $827MQ3'25Q4'25, Cash and equivalents: $854MQ4'25, Long-term debt: $1.2BQ1'26, Cash and equivalents: $578MQ1'26, Long-term debt: $1.2BQ1'26Q2'26, Cash and equivalents: $517MQ2'26, Long-term debt: $1.2BQ3'26, Cash and equivalents: $499MQ3'26, Long-term debt: $1.1BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

GENPACT LIMITED income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 12, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue1,3851,3431,2961,3191,2911,2541,2151,249+7.3%
Cost of revenue859853824837822804786803+4.5%
Gross profit527490472482470450429446+12.1%
Research and development—————————
Selling, general and administrative312294270277262266241249+19.2%
Operating income211193199195192179184190+10.1%
Other income (expense)1110371025−84.8%
Pretax income196191194189189177175183+3.8%
Income tax4545464644444441+2.9%
Net income152146148143146133131142+4.0%
Diluted EPS ($)0.890.860.86—0.830.750.73—+7.2%
Diluted shares (millions)170170173—176177178——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

GENPACT LIMITED balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 12, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents499517578854741663562648−32.6%
Short-term investments0035035000023—
Total current assets2,3382,1712,4052,6562,2122,1351,9432,080+5.7%
Total assets5,6395,4135,6175,8435,3645,3084,8954,987+5.1%
Total current liabilities1,1991,0881,4261,6021,4621,392792964−18.0%
Long-term debt1,1481,1541,1601,1668278331,1891,195+38.8%
Total debt1,1741,1801,5361,5421,2031,2941,2151,221−2.4%
Total liabilities2,9312,8083,1423,2942,8202,7212,4422,598+3.9%
Stockholders’ equity2,7092,6052,4752,5492,5452,5872,4532,390+6.4%
Shares outstanding (millions)167168170170172174175176—

Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.

GENPACT LIMITED cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 6, 2026Q2 FY2026ended Jun 30, 2026filed Aug 7, 2026Q1 FY2026ended Mar 31, 2026filed May 8, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 12, 2025Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow9372(24)28730817740203−69.8%
Capital expenditures1714241816222220+2.2%
Free cash flow (CFO − capex)7659(47)26929215518184−73.8%
Depreciation and amortization2121212626222124−18.5%
Share repurchases—————————
Dividends paid3132322929303027+7.3%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 26, 2026.

Income statement

GENPACT LIMITED income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 29, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Mar 2, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Dec 31, 2010filed Mar 1, 2011FY2009ended Dec 31, 2009filed Aug 9, 2010FY2008ended Dec 31, 2008filed Aug 9, 2010
Revenue5,0804,7674,4774,3714,0223,7093,5213,0012,7372,5712,4612,2792,1321,9021,6001,2591,1201,041
Cost of revenue3,2493,0772,9062,8352,5902,4182,2951,9221,6811,5541,4941,3781,3201,1581,005789673619
Gross profit1,8311,6901,5711,5361,4321,2911,2261,0791,0551,016967901812744596470447422
Research and development——————————————————
Selling, general and administrative1,047967913938866790795694689653608586485457358282265255
Operating income750702631502509439429348331341334294310264216178162134
Other income (expense)2219150133636241042(24)(14)11547
Pretax income730677602465483400399362321330302250306263262184161144
Income tax178163(29)1121149295816062625771787134259
Net income552514631353369308305282263270240192230178184142127125
Diluted EPS ($)3.132.853.411.881.911.571.561.451.341.281.090.850.970.780.810.630.580.57
Diluted shares (millions)177180185188193196195194197210219225236230226225220218

Balance sheet

GENPACT LIMITED balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 29, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Mar 2, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Dec 31, 2010filed Mar 1, 2011FY2009ended Dec 31, 2009filed Aug 9, 2010FY2008ended Dec 31, 2008filed Aug 9, 2010
Cash and equivalents854648584647899680467368504423451462571459408404289184
Short-term investments350230———————————————
Total current assets2,6562,0801,8921,7791,9221,7491,5521,3551,4341,2271,1951,1891,2761,129985936846—
Total assets5,8434,9874,8064,5894,9754,8744,4543,5293,4502,8862,7932,7432,6892,6062,4031,8931,748—
Total current liabilities1,6029641,3181,1031,3091,203910976839731594622462518662323396—
Long-term debt1,1661,1958251,2491,2721,3071,3409761,007698737649654657742525—
Total debt1,5421,2211,2671,4261,6561,5911,4431,3041,2168977987896587423552570—
Total liabilities3,2942,5982,5572,7633,0783,0392,7652,1252,0211,5951,4891,4571,3651,434968412548—
Stockholders’ equity2,5492,3902,2481,8261,8971,8341,6891,4041,4241,2871,3041,2851,3231,1681,4331,4791,197—
Shares outstanding (millions)170176181184185188190189193199211220232227222221——

Cash flow statement

GENPACT LIMITED cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Mar 3, 2025FY2023ended Dec 31, 2023filed Feb 29, 2024FY2022ended Dec 31, 2022filed Mar 1, 2023FY2021ended Dec 31, 2021filed Mar 1, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Mar 2, 2020FY2018ended Dec 31, 2018filed Mar 1, 2019FY2017ended Dec 31, 2017filed Mar 1, 2018FY2016ended Dec 31, 2016filed Mar 1, 2017FY2015ended Dec 31, 2015filed Feb 26, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Mar 1, 2013FY2011ended Dec 31, 2011filed Feb 29, 2012FY2010ended Dec 31, 2010filed Mar 1, 2011FY2009ended Dec 31, 2009filed Aug 9, 2010FY2008ended Dec 31, 2008filed Aug 9, 2010
Operating cash flow813615491444694584428340359346—272312311267163158211
Capital expenditures788355515370758557826263498336555362
Free cash flow (CFO − capex)735533435393641514353255302264—209263227231108106149
Depreciation and amortization959610413016816012910495828380767978748092
Share repurchases—25322521429813730154220345227303——————
Dividends paid118108100928074655747—————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$9M
4 sales by 4 insiders; officers and directors $9M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$13M
12 sales by 7 insiders; officers and directors $13M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Nov 10, 2026Mehta PiyushSenior Vice President and CHROoption exercise200,000$27.70$6M356,823Nov 13, 2026
Nov 10, 2026Mehta PiyushSenior Vice President and CHROopen-market sale200,000$43.05$9M156,823Nov 13, 2026
Nov 9, 2026Lindstrom CarolDirectoropen-market sale2,364$42.56$101K25,342Nov 12, 2026
Sep 14, 2026Kalra BalkrishanPresident and CEO, Directoropen-market sale10,000$36.79$368K501,114Sep 16, 2026
Sep 9, 2026Pandit SumitaChief Financial Officeraward76,713$0.00—76,713Sep 11, 2026
Aug 19, 2026Nanduru AnilSenior Vice Presidentopen-market sale6,191$37.03$229K70,253Aug 20, 2026
Aug 14, 2026Dewan SameerSenior Vice Presidentopen-market sale1,654$34.10$56K56,011Aug 18, 2026
Aug 14, 2026Dewan SameerSenior Vice Presidentopen-market sale13,318$34.10$454K42,693Aug 18, 2026
Aug 13, 2026Weiner Michael HalChief Financial Officeropen-market sale5,900$34.04$201K176,027Aug 14, 2026
Aug 12, 2026Nanduru AnilSenior Vice Presidentopen-market sale11,852$33.92$402K76,444Aug 13, 2026
Aug 11, 2026Nanduru AnilSenior Vice Presidentopen-market sale17,243$33.96$586K88,296Aug 13, 2026
Apr 23, 2026Hinshaw John MDirectoraward6,521$0.00—8,855Apr 27, 2026
Apr 23, 2026Morken CeCeliaDirectoraward6,521$0.00—64,281Apr 27, 2026
Apr 23, 2026Lindstrom CarolDirectoraward6,521$0.00—27,706Apr 27, 2026
Apr 23, 2026Gangestad Nicholas CDirectoraward6,521$0.00—15,334Apr 27, 2026
Apr 23, 2026Subaiya Thimaya K.Directoraward6,521$0.00—8,541Apr 27, 2026
Apr 23, 2026Verdi Mark ADirectoraward6,521$0.00—71,526Apr 27, 2026
Apr 23, 2026Stevens Brian MarkDirectoraward6,521$0.00—36,619Apr 27, 2026
Apr 23, 2026Conigliaro LauraDirectoraward6,521$0.00—79,337Apr 27, 2026
Apr 23, 2026Madden James C.Directoraward9,999$0.00—73,067Apr 27, 2026
Mar 10, 2026Weiner Michael HalChief Financial Officertax withholding7,019$38.92$273K181,874Mar 12, 2026
Mar 10, 2026Vashisht RijuSenior Vice Presidenttax withholding7,080$38.92$276K123,668Mar 12, 2026
Mar 10, 2026Nanduru AnilSenior Vice Presidenttax withholding7,663$38.92$298K105,539Mar 12, 2026
Mar 10, 2026Mehta PiyushSenior Vice President and CHROtax withholding5,702$38.92$222K156,485Mar 12, 2026
Mar 10, 2026Dewan SameerSenior Vice Presidenttax withholding3,542$38.92$138K57,665Mar 12, 2026

Full insider history for GENPACT LIMITED, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
GENPACT LIMITED, CIK 1398659 on EDGAR
Extract generated
November 16, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: other income FY2015
Repaired
2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2012, other income FY2022
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueServicesNet
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total debt: LongTermDebt, LongTermDebt+short-term, noncurrent+current+short-term
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: not filed
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 16, 2026.

JSON file
/data/financials/G.json